All Articles

As March Networks and VIVOTEK merge their AI surveillance tech at APTA 2026, transit agencies gain powerful tools—and citizens face a new era of tracking.

Om Mushrooms’ new Lion’s Mane booster delivers cognitive benefits without altering your coffee’s taste, signaling a major shift in functional wellness.

The NHS rollout of Tryngolza offers a monthly RNA-targeted lifeline for FCS patients, proving the practical value of execution in genetic lipid disorders.

A new campaign highlights how pre-packaging surgical trays to save ten minutes of prep time could alleviate the structural crisis facing European hospitals.

A proposed year-round sightseeing tram near Glacier National Park tests the balance between accessible tourism, economic growth, and wilderness preservation.

Nextdoor's move to the Nasdaq Capital Market highlights a broader tech sector shift toward operational efficiency and post-SPAC financial right-sizing.

As a critical FDA decision looms for its lead drug, Hansa Biopharma partners with Cradle to build a sustainable, AI-driven autoimmune discovery engine.

With over 700,000 annual deaths, liver cancer is a global crisis. Yet 60% of cases are preventable. We explore the gap between innovation and patient access.

HoneyNaps is transforming clinical trials by turning its FDA-cleared AI diagnostic software into a specialized Contract Research Organization for sleep data.

As EU aviation mandates tighten, Uniper's capacity reservation for Syzygy’s light-driven SAF platform signals a strategic pivot toward Latin American supply.

As data centers drain the grid, Apollo and GDEV are quietly consolidating rural run-of-river hydro to secure clean, reliable baseload power.

Rakovina Therapeutics is teaming up with Celvion to leverage real-world AI data, aiming to bypass clinical hurdles and de-risk its ATR inhibitor pipeline.

As the 2026 Paris Motor Show kicks off, a Chinese tech giant is rewriting the playbook, challenging Tesla on autonomy while building cars and robots in Europe.

As electrical grids struggle with megawatt-scale charging, a new off-grid hydrogen field lab in Rotterdam offers a heavy-lifting alternative for port logistics.

AI delivers undeniable ROI, yet only 13% of organizations successfully scale it. Discover the hidden workforce and regulatory costs stalling progress.

As InCorp rebrands to Ascentium Singapore, a massive consolidation wave reveals a shift from back-office compliance to human-centric growth ecosystems.

By appointing Dr. Rajesh Chopra as CSO, Swiss biotech Numab Therapeutics signals a strategic pivot toward clinical execution for its trispecific IBD pipeline.

As trade barriers rise, Chinese automaker Chery deploys its futuristic OMODA X to capture European youth and redefine the global crossover market.

Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, signaling a major shift in European biopharma infrastructure.

As GLP-1 drugs face scrutiny for causing lean tissue loss, advanced MRI biomarkers are reshaping clinical trials and the future of metabolic medicine.